A new study has found that at least five different brain-attacking diseases strike different parts of the human language network. Conducted by researchers at Northwestern University’s Mesulam Center for Cognitive Neurology and Alzheimer’s Disease and published in the journal Brain, the findings suggests that not only is it time to shift the way brain diseases are diagnosed but it’s also time to change the approach to treatment when patients exhibit language impairment.
Primary Progressive Aphasia
Primary progressive aphasia (PPA) is a neurodegenerative disease that selectively impairs language without affecting speech or memory. It comes in many forms, explains Marsel Mesulam, lead author of the study and director of the Mesulam Center. An estimated one in 100,000 people have PPA, he says, and because early symptoms are subtle, they are often ignored or misdiagnosed as anxiety or throat issues. This lack of timeliness in diagnosing, even by specialists, is problematic, he adds.
He and his colleagues looked at 118 cases — the largest set of PPA autopsies ever assembled — whom Mesulam had followed for more than 25 years prior to their deaths. That makes it "the most extensive study to date on life expectancy, type of language impairment and relationship of disease to details of language impairment,” he says.
The researchers found that the different language issues associated with PPA are actually caused by different diseases. In other words, there isn't one singular brain disease or “dementia” that leaves people struggling to communicate, but rather many different diseases that target different parts of the brain and cause various types of PPA.
1. Alzheimer’s disease
Alzheimer’s, a type of dementia that affects memory, thinking and behavior, accounted for 42 percent of cases in the latest study. Symptoms eventually grow severe enough to interfere with daily tasks. However, in certain cases such as these, Alzheimer’s can impair language rather than memory.
Symptoms may include:
Poor judgment leading to bad decisions.
Loss of spontaneity and sense of initiative.
Taking longer to complete normal daily tasks.
Trouble handling money and paying bills.
Losing things or misplacing them in odd places.
2. Corticobasal degeneration and progressive supranuclear palsy
These diseases together accounted for 24 percent of cases in the latest study. CBD occurs when increasing numbers of brain cells become damaged and die over time. Those who suffer from this rare condition may experience worsening problems with movement, speech, memory and swallowing.
Some symptoms of corticobasal degeneration may include:
Difficulty controlling your limb on one side of the body – a “useless” hand)
Shaking (tremors), jerky movements and spasms (dystonia)
Problems with balance and coordination
Slow and slurred speech
Symptoms of dementia, such as memory and visual problems
Slow, effortful speech
3. Pick’s disease
Pick’s disease, a kind of dementia similar to Alzheimer’s but far less common, was responsible for 10 percent of cases in the study. It impacts the parts of the brain that control emotions, behavior, personality and language. This falls under the category of frontotemporal lobar degeneration, which is responsible for about half of all dementias starting before the age of 65.
Symptoms may include:
Acting aggressively toward others
Being uninterested in everyday activities
Drastic mood swings
Trouble with unplanned activities
Making rash decisions
Saying and doing inappropriate things
Neurological changes such as the few listed below are also to be expected:
Reduced writing or reading skills
Echoing, or repeating what’s been said to you
Inability to speak, difficulty speaking, or trouble understanding speech
Accelerated memory loss
The final two brain diseases included in the research were transactive response DNA binding proteinopathy type A and type C, which accounted for 10 percent and 11 percent of cases respectively.
Knowing which disease has attacked the brain and where means a lesser chance that a treatment may be misdirected. In the past, the only way to make a final diagnosis was an autopsy. But, today, medical advancements like MRIs, spinal taps and blood assays can find biomarkers and enable a definitive diagnosis while the person is alive.
The first goal is to both diagnose the underlying diseases and treat them, says Mesulam. If Alzheimer’s disease is the cause of language impairment, a patient may be treated with medication or directed to take part in clinical trials. Likewise, a patient who is suffering from language challenges specific to grammar and word-finding may be directed into speech therapy.
The second goal is to study those with PPA even more deeply and learn more about language in the human brain — “which is the only unique function of the human brain and what makes our brain human,” says Mesulam.
“I wish we could have done more […] for the 118 patients of mine that I've followed for years who have died,” he says. “But this remarkable gift of tissue that our patients have given to us [can be used] to learn the cellular basis of why the disease goes out of its way to find a piece of the brain on the left side and hit it and destroy it.”